In addition, loading miR-145 on a gold nanoplatform functionalized with FSH33 peptide can deliver miR-145 to ovarian cancer cells and decrease VEGF release and endothelial cell proliferation (Salas-Huenuleo et al., 2022[109]). Here, VEGFA is linked to ovarian carcinoma.